Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.82 USD | -0.65% |
|
-3.95% | -1.68% |
| 24/07 | Edwards Lifesciences beats quarterly estimates on strong demand for heart devices | RE |
| 24/07 | Edwards Lifesciences Q2 Adjusted Earnings, Revenue Rise; Q3 Guidance Set | MT |
| Market Cap | 4.86TCr 4.27TCr 3.97TCr 3.65TCr 6.84TCr 4,69100Cr 6.97TCr 47TCr 18TCr 2,29100Cr 18TCr 18TCr 7,95800Cr | P/E 2026 * |
30x | P/E 2027 * | 25.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.53TCr 3.98TCr 3.7TCr 3.4TCr 6.38TCr 4,37500Cr 6.5TCr 44TCr 17TCr 2,13600Cr 17TCr 17TCr 7,42100Cr | EV / Sales 2026 * |
6.72x | EV / Sales 2027 * | 5.89x |
| Free-Float |
87.23% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | -0.65% | ||
| 1 week | -3.95% | ||
| Current month | -7.34% | ||
| 1 month | -2.40% | ||
| 3 months | +2.81% | ||
| 6 months | -0.73% | ||
| Current year | -1.68% |
| 1 week | 82.99 |  | 87.06 |
| 1 month | 82.99 | | 96.29 |
| Current year | 74.66 | | 96.29 |
| 1 year | 72.3 | | 96.29 |
| 3 years | 58.93 | | 96.29 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 11/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 29/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 01/09/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 07/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 10/02/2015 |
| Director/Board Member | 58 | 11/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/07/26 | Tax | Executive/Senior Manager | -109 | 0.0000% | ||
| 10/07/26 | Fiscal year | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 09/07/26 | Free | Chief Financial Officer | 1,74,045 | 0.0302% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.65% | -3.95% | +9.86% | -9.45% | 4.86TCr | |
| +8.71% | +6.92% | +33.84% | +1.80% | 20TCr | |
| +7.46% | -4.13% | +1.36% | -24.77% | 13TCr | |
| -2.54% | -14.64% | -35.03% | -1.38% | 12TCr | |
| +1.42% | +1.25% | -57.75% | -18.02% | 6.39TCr | |
| -1.56% | -2.07% | -25.50% | -33.72% | 4.39TCr | |
| +4.71% | +3.73% | +20.27% | +9.50% | 3.77TCr | |
| +3.13% | +2.00% | +33.03% | +32.45% | 3.64TCr | |
| +3.14% | +5.19% | +92.94% | +3.34% | 2.89TCr | |
| +0.94% | -1.91% | -18.96% | -24.98% | 2.79TCr | |
| Average | +1.76% | -3.33% | +5.41% | -6.52% | 7.29TCr | |
| Weighted average by Cap. | +2.86% | -4.91% | +3.25% | -6.97% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 674.31Cr 592.58Cr 550.68Cr 506.45Cr 949.54Cr 65TCr 967.74Cr 6.57TCr 2.56TCr 32TCr 2.53TCr 2.48TCr 1,10500Cr | 740.54Cr 650.78Cr 604.76Cr 556.19Cr 1.04TCr 72TCr 1.06TCr 7.21TCr 2.82TCr 35TCr 2.78TCr 2.72TCr 1,21300Cr |
| Net income | 161.78Cr 142.17Cr 132.12Cr 121.51Cr 227.82Cr 16TCr 232.18Cr 1.58TCr 615.36Cr 7.63TCr 607.25Cr 594.21Cr 27TCr | 188.09Cr 165.29Cr 153.61Cr 141.27Cr 264.87Cr 18TCr 269.94Cr 1.83TCr 715.43Cr 8.87TCr 706.01Cr 690.85Cr 31TCr |
| Net Debt | -327.76Cr -288.03Cr -267.66Cr -246.17Cr -461.54Cr -32TCr -470.38Cr -3.19TCr -1.25TCr -15TCr -1.23TCr -1.2TCr -54TCr | -496.99Cr -436.75Cr -405.87Cr -373.27Cr -699.85Cr -48TCr -713.26Cr -4.84TCr -1.89TCr -23TCr -1.87TCr -1.83TCr -81TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | $83.82 | -0.65% | 67,09,709 |
| 22/26/22 | $84.37 | -0.21% | 45,12,283 |
| 21/26/21 | $84.55 | -0.53% | 55,71,029 |
| 20/26/20 | $85.00 | -0.85% | 37,51,422 |
| 17/26/17 | $85.73 | -2.40% | 52,25,093 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
